Sericin Market Size, Share, Growth, and Industry Analysis, By Type (Solid,Liquid), By Application (Pharmaceuticals,Cosmetics and Personal Care,Textiles,Food), Regional Insights and Forecast to 2035

Sericin Market Overview

The global Sericin Market is forecast to expand from USD 370.9 million in 2026 to USD 393.97 million in 2027, and is expected to reach USD 640.76 million by 2035, growing at a CAGR of 6.22% over the forecast period.

The global Sericin market size is estimated at USD 2.02 billion in 2024 and expected to reach USD 5.55 billion by 2034 under existing projections. Sericin, a silk protein comprising about 20-30% of raw silk cocoon composition, is increasingly utilized for its moisturizing, antioxidant, UV-protective, anti‐inflammatory, and wound-healing properties. In the USA Sericin Market Report, North America accounted for more than 40% of global market revenue in 2024, with the USA itself contributing roughly USD 164.9 million in Sericin demand in 2024 via personal care & cosmetics, pharmaceuticals, and functional textiles. USA usage of solid sericin is dominant in cosmetics (over 60% of form share in some reports), with liquid sericin gaining traction in hair care and skin care formulations.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Approximately 65-70% of personal care manufacturers globally now incorporate natural proteins like sericin; about 55% of survey respondents list antioxidant properties; 48% adoption in wound healing R&D.
• Major Market Restraint: Roughly 30-35% of producers cite high extraction and purification costs; 25% report inconsistent raw silk sericin quality; 20% mention regulatory hurdles for medical‐grade applications.
• Emerging Trends: About 55-60% of Sericin Market Research Reports highlight hydrolyzed sericin; 50% note encapsulation / nano‐delivery forms; 40% indicate vegan/cruelty-free sourcing demand.
• Regional Leadership: North America holds over 40% market share; Europe around 30-35%; Asia-Pacific about 22-25%; Middle East & Africa plus Latin America under 10% combined.
• Competitive Landscape: Approximately 70% of key players offer both solid and liquid forms; 60% have cosmetic grade certification; 50% have medical grade R&D programs.
• Market Segmentation: Solid sericin accounts for about 60-65% of form usage; liquid sericin around 35-40%; cosmetics & personal care make up ~60-65% of application demand; pharmaceuticals ~10-15%.
• Recent Development: Nearly 75% of new Sericin Market Trends in 2024 include sustainable sourcing; 45% include advanced extraction methods; 30% include multifunctional formulations (skin + hair + wound).

Sericin Market Latest Trends

In recent Sericin Market Trends, solid sericin remains the prevalent product form, generating roughly 60-65% of form demand, especially in cosmetics & personal care and textiles. Liquid sericin, comprising ~35-40% of form usage, is gaining popularity in hair care and skin care serums due to better blending with aqueous formulations. Hydrolyzed sericin, used in pharmaceuticals and functional food, is increasingly featured in research. Application segmentation shows cosmetics & personal care commanding ~60-65% of total demand, pharmaceuticals around 10-15%, textiles ~8-12%, food & beverages approx 5-8%. Among regions, North America leads with over 40% share in 2024, Europe at 30-35%, Asia-Pacific ~22-25%, remaining regions combined under 10%. Trends in extraction show more use of enzymatic and green chemistry methods (~45-50% of R&D reports) to reduce waste and improve bioactivity. Vegan, cruelty-free, ethical sourcing are emphasized by ~50-55% of cosmetic product launches involving sericin in 2024. Multifunctional formulations (moisturizing + anti-ageing + UV protection) appear in around 40% of new sericin-based skincare products. Meanwhile, biomedical uses like wound dressings, tissue engineering, and drug delivery represent about 10-15% of published application reports, indicating that Sericin Industry Analysis must address regulatory, purity, and clinical validation trends.

Sericin Market Dynamics

DRIVER

"Rising demand for natural, bio-based materials in cosmetics and medical applications."

In this driver domain, usage of sericin in cosmetics & personal care accounts for ~60-65% of application demand, particularly in moisturizers, anti-aging serums, skin repair products. The protein’s antioxidant and moisturizing properties are cited in ~55-60% of R&D studies. Use in pharmaceutical research (wound healing, drug delivery) is featured in ~10-15% of published academic and industry trials. Extraction from silkworm cocoon, pupa, and even silk degumming wastewater shows in about 40-45% of industry reports. Bioactive purity levels (proteins of molecular weight 20-400 kDa) are demanded in ~50% of medical grade sericin specifications.

RESTRAINT

"High production cost, raw material variability, and regulatory barriers."

High production/purification cost is cited in ~30-35% of producer surveys; raw silk quality (sericin content, contaminants) varies by 20-30% between batches in many Asian providers. Regulatory compliance for medical or pharmaceutical use demands high purity, endotoxin limits, bioactivity standardization, mentioned in ~25-30% of product registration cases. Liquid sericin is less stable than solid form; reports indicate ~20-25% formulation loss in stability tests under heat or UV for liquid form. Yield from cocoon degumming: about 15-25% of silk mass becomes sericin, thus limiting volume. In many regions, silk cocoon output fluctuates by 10-20% year-to-year due to environmental, labor constraints, reducing supply reliability.

OPPORTUNITY

"Expansion into pharmaceuticals, textiles, and vegan / cruelty-free markets."

In pharmaceuticals, applications such as wound healing and drug delivery are featured in ~10-15% of research reports; tissue engineering studies using sericin represent about 5-8% of all biomaterials papers in 2024. In textiles, sericin is increasingly used as coating or finishing agent in ~8-12% of functional fabric lines (softness, moisture control). Food & beverages / nutraceuticals are now using sericin as additive in about 5-8% of new functional food product filings. Vegan / cruelty-free labeling demanded by ~50-55% of cosmetic product launches in Europe and North America; this creates opportunity for sericin suppliers who can assure no‐animal low-impact sourcing.

CHALLENGE

"Purity, scale, and standardization issues constrain growth and adoption."

Purity: many sericin extracts contain impurities; about 30-40% of quality failures in trials relate to bacterial contamination or endotoxin levels. Scale: industrial silk cocoon production is concentrated in Asia; about 70-80% of global sericin raw input comes from China, India, South Korea, Japan, which introduces geographic risk if supply disrupted. Standardization: molecular weight of sericin ranges between 20-400 kDa, but about 40-50% of product datasheets do not specify molecular weight, causing inconsistency. Cost: purification and extraction create ~25-30% of total product cost; about 20-25% of companies report high unit cost vs synthetic alternatives limits competitiveness.

Sericin Market Segmentation

Overall segmentation includes product form (type) and application.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Solid: Solid sericin, including powdered, freeze‐dried or spray‐dried, holds about 60-65% of global form demand; widely used in cosmetics / personal care for creams, face masks, anti-aging products (~35-40% of cosmetics usage uses solid form). Medical / pharmaceutical usage of solid form accounts for roughly 10-12% of total solid form usage.

Solid Sericin market size is expected to be USD 213.51 million in 2025, accounting for 61.1% share, and projected to reach USD 364.96 million by 2034, registering a CAGR of 6.27%.

Top 5 Major Dominant Countries in the Solid Segment

• United States market size of USD 61.91 million in 2025 with 29% share, expected to reach USD 103.42 million by 2034 at a CAGR of 6.08%, supported by cosmetics and healthcare use.
• China valued at USD 55.51 million in 2025 with 26% share, projected to USD 95.33 million by 2034 at a CAGR of 6.47%, driven by large-scale sericulture output.
• Japan estimated at USD 33.36 million in 2025 with 15.6% share, reaching USD 57.12 million by 2034 at a CAGR of 6.35%, with growth in pharmaceuticals.
• Germany market at USD 31.19 million in 2025 with 14.6% share, increasing to USD 52.62 million by 2034 at a CAGR of 6.08%, driven by cosmetics formulations.
• India valued at USD 31.54 million in 2025 with 14.8% share, projected to USD 56.47 million by 2034 at a CAGR of 6.67%, led by expanding textiles and food industries.

Liquid: Liquid sericin (including hydrolyzed and solution / extract forms) comprises ~35-40% of form demand. It is preferred in skin care serums, hair care treatments, toners; in cosmetics, ~40-50% of new launches using sericin chose liquid form. Liquid/hydrolyzed sericin also used in pharmaceutical formulations (transdermal, wound dressings) representing about 5-8% of liquid form demand.

Liquid Sericin market size is estimated at USD 135.67 million in 2025, representing 38.9% share, and forecasted to reach USD 236.29 million by 2034, growing at a CAGR of 6.14%.

Top 5 Major Dominant Countries in the Liquid Segment

• United States at USD 42.03 million in 2025 with 31% share, projected to USD 71.25 million by 2034 at a CAGR of 6.10%, supported by premium skincare and biotech.
• China valued at USD 39.34 million in 2025 with 29% share, expected to reach USD 69.21 million by 2034 at a CAGR of 6.21%, driven by haircare demand.
• Japan estimated at USD 20.35 million in 2025 with 15% share, growing to USD 35.14 million by 2034 at a CAGR of 6.28%, supported by functional personal care.
• France market size of USD 18.99 million in 2025 with 14% share, forecasted to reach USD 32.39 million by 2034 at CAGR of 6.11%, driven by cosmetic innovations.
• South Korea valued at USD 15.02 million in 2025 with 11% share, projected to USD 28.30 million by 2034 at a CAGR of 6.80%, led by K-beauty expansion.

BY APPLICATION

Pharmaceuticals: The pharmaceuticals application segment accounts for ~10-15% of total sericin application demand. Within pharmaceutical uses, wound healing, tissue engineering, and drug delivery are most common (representing ~60-70% of pharmaceutical sericin uses).

Pharmaceuticals Sericin market size is USD 41.90 million in 2025, accounting for 12% share, and projected to reach USD 74.20 million by 2034 at CAGR of 6.44%.

Top 5 Major Dominant Countries in the Pharmaceuticals Application

• United States at USD 14.26 million in 2025 with 34% share, projected to USD 24.14 million by 2034 at CAGR of 6.10%, driven by wound-healing R&D.
• China valued at USD 8.81 million in 2025 with 21% share, expected to reach USD 16.09 million by 2034 at CAGR of 6.82%, supported by biotech studies.
• Germany estimated at USD 6.70 million in 2025 with 16% share, growing to USD 11.87 million by 2034 at CAGR of 6.45%, linked to medical-grade sericin.
• Japan market size of USD 6.29 million in 2025 with 15% share, projected to USD 11.34 million by 2034 at CAGR of 6.58%, supported by biomaterials research.
• India valued at USD 5.84 million in 2025 with 14% share, reaching USD 10.76 million by 2034 at CAGR of 6.72%, with applications in tissue repair.

Cosmetics and Personal Care: This is the largest application, approximately 60-65% of total market demand. Cosmetic form includes skin care (~35-40% of cosmetics uses), hair care (~20-25%), anti-ageing / anti-wrinkle treatments (~10-15%), body care / masks / lotions (~5-10%). Personal care lines also include sun protection, whitening, moisturizing blends; product launches in 2023‐2024 show ~50% new sericin products are skincare serums or creams.

Cosmetics and Personal Care Sericin market is USD 197.55 million in 2025, holding 56.6% share, projected to reach USD 338.43 million by 2034 at CAGR of 6.22%.

Top 5 Major Dominant Countries in the Cosmetics and Personal Care Application

• United States at USD 54.13 million in 2025 with 27.4% share, forecasted to reach USD 92.20 million by 2034 at CAGR of 6.14%, driven by anti-aging products.
• China valued at USD 47.41 million in 2025 with 24% share, projected to USD 82.65 million by 2034 at CAGR of 6.35%, supported by skincare expansion.
• Japan estimated at USD 33.63 million in 2025 with 17% share, expected to reach USD 58.55 million by 2034 at CAGR of 6.32%, driven by haircare.
• Germany market at USD 31.61 million in 2025 with 16% share, projected to USD 53.48 million by 2034 at CAGR of 6.15%, linked to natural cosmetics.
• France valued at USD 30.77 million in 2025 with 15.6% share, reaching USD 51.55 million by 2034 at CAGR of 6.12%, supported by premium beauty.

Textiles: Textiles represent ~8-12% of application usage. Uses include silk fabric finishing, functional textiles imparting moisture control, softness, UV protection. Many textile producers in Asia Pacific use sericin as finishing agent; in silk material production, sericin content affects dye uptake and texture. In some countries, ~20-25% of silk weaving firms apply sericin as finishing.

Textiles Sericin market size is USD 71.34 million in 2025, representing 20.4% share, expected to reach USD 124.19 million by 2034 at CAGR of 6.26%.

Top 5 Major Dominant Countries in the Textiles Application

• China at USD 23.94 million in 2025 with 33.6% share, reaching USD 42.62 million by 2034 at CAGR of 6.37%, supported by silk industry.
• India valued at USD 19.06 million in 2025 with 26.7% share, expected to reach USD 34.87 million by 2034 at CAGR of 6.41%, driven by apparel finishing.
• Japan estimated at USD 11.41 million in 2025 with 16% share, growing to USD 19.92 million by 2034 at CAGR of 6.28%, supported by functional fabrics.
• Italy market at USD 9.63 million in 2025 with 13.5% share, projected to USD 16.47 million by 2034 at CAGR of 6.17%, linked to luxury textiles.
• Brazil valued at USD 7.30 million in 2025 with 10.2% share, reaching USD 12.31 million by 2034 at CAGR of 6.02%, supported by fashion exports.

Food: Food & beverages / nutraceuticals account for ~5-8% of application demand. Uses include functional food additives, dietary supplements, possibly in edible films and packaging. Studies show sericin has antioxidant capacity and potential in food preservation; about 15-20 studies in 2023‐2024 explored incorporation in food matrices.

Food Sericin market is USD 38.39 million in 2025, holding 11% share, projected to reach USD 64.43 million by 2034 at CAGR of 6.01%.

Top 5 Major Dominant Countries in the Food Application

• China at USD 11.51 million in 2025 with 30% share, expected to reach USD 19.50 million by 2034 at CAGR of 6.07%, supported by functional foods.
• United States valued at USD 9.97 million in 2025 with 26% share, projected to USD 16.71 million by 2034 at CAGR of 6.08%, linked to nutraceuticals.
• Japan estimated at USD 7.30 million in 2025 with 19% share, reaching USD 12.28 million by 2034 at CAGR of 6.02%, supported by dietary supplements.
• Germany market at USD 5.37 million in 2025 with 14% share, growing to USD 9.04 million by 2034 at CAGR of 6.10%, with applications in functional beverages.
• India valued at USD 4.24 million in 2025 with 11% share, projected to USD 6.90 million by 2034 at CAGR of 5.68%, with growth in health foods.

Sericin Market Regional Outlook

North America leads the Sericin Market with over 40% share in 2024, followed by Europe with 30-35%, Asia-Pacific with approx 22-25%, while Middle East & Africa and Latin America together form under 10% share. Key region-specific patterns include high demand in skincare launches, strong regulation in Europe, production concentration in Asia, and growth potential in MEA due to cost-sensitive natural product interest and silk byproduct availability.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America’s Sericin Market delivered about USD 164.9 million in 2024, constituting over 40% of the global sericin market value. Demand is especially strong in the USA, where cosmetics and skin care product launches featuring sericin account for more than 50% of new protein-based ingredients introductions. Solid form dominates North American usage, making up about 60-65% of form consumption in the region; liquid sericin forms roughly 35-40%. Application distribution in North America: personal care & cosmetics contribute nearly 65-70% of regional usage; pharmaceuticals about 10-12%; textiles and food & beverages combined less than 10%.

The North America Sericin market is USD 118.92 million in 2025 with 34% share, projected to reach USD 201.48 million by 2034 at CAGR of 6.08%, supported by cosmetics and pharmaceuticals growth.

North America - Major Dominant Countries in the Sericin Market

• United States at USD 96.16 million in 2025 with 80.9% share, projected to USD 162.91 million by 2034 at CAGR of 6.01%, dominating regional demand.
• Canada valued at USD 11.89 million in 2025 with 10% share, expected to reach USD 21.08 million by 2034 at CAGR of 6.57%, with rising personal care usage.
• Mexico at USD 6.54 million in 2025 with 5.5% share, growing to USD 11.25 million by 2034 at CAGR of 6.03%, supported by textile sector.
• Puerto Rico market size of USD 2.27 million in 2025 with 1.9% share, forecasted to reach USD 3.95 million by 2034 at CAGR of 6.11%, linked to food additives.
• Cuba valued at USD 2.06 million in 2025 with 1.7% share, projected to USD 3.29 million by 2034 at CAGR of 5.37%, reflecting slow expansion.

Europe

Europe holds approximately 30-35% of global sericin market share in 2024, making it second only to North America. The region’s demand is led by sustainable / clean beauty trends, with over 50% of cosmetic brands in Western Europe launching sericin-based skincare or hair care products in 2023-2024. Form usage in Europe: solid sericin has roughly 60-65% share; liquid sericin ~35-40%. Application split: cosmetics & personal care contribute ~60-65% of regional demand; pharmaceuticals ~10-15%; textiles ~8-12%; food & beverages ~5-7%. Countries leading: Germany, UK, France, Italy, Spain. Germany product certification and bioactive purity standards are particularly rigorous; about 40-45% of sericin medical-grade trials in Europe are based in Germany.

The Europe Sericin market is USD 105.82 million in 2025 with 30.3% share, projected to reach USD 181.60 million by 2034 at CAGR of 6.19%, supported by cosmetics and textiles industries.

Europe - Major Dominant Countries in the Sericin Market

• Germany at USD 31.19 million in 2025 with 29.5% share, projected to USD 52.62 million by 2034 at CAGR of 6.08%, driven by cosmetics.
• France valued at USD 24.36 million in 2025 with 23% share, reaching USD 41.58 million by 2034 at CAGR of 6.37%, with premium skincare demand.
• United Kingdom estimated at USD 19.47 million in 2025 with 18.4% share, growing to USD 33.33 million by 2034 at CAGR of 6.24%, supported by biotech.
• Italy market at USD 17.12 million in 2025 with 16.2% share, expected to reach USD 29.40 million by 2034 at CAGR of 6.18%, linked to textiles.
• Spain valued at USD 13.68 million in 2025 with 12.9% share, projected to USD 24.67 million by 2034 at CAGR of 6.36%, supported by natural cosmetics.

Asia-Pacific

Asia-Pacific accounts for approx 22-25% of global sericin market in 2024, with China, India, Japan, South Korea, and Southeast Asia being major contributors. China leads raw material supply, producing over 60-70% of global silk cocoon output, yielding large sericin extraction volume. Application demand in Asia-Pacific: cosmetics & personal care ~55-60% of regional usage; pharmaceuticals ~10-12%; textiles ~15-20% (higher than in Western markets); food & nutraceutical uses ~5-8%. Form usage: in Asia, liquid sericin is more accepted in hair care and skincare serums—about 40-45% of Asia-Pacific sericin use is liquid; solid ~55-60%. Product innovation: ~30-35 new sericin-based cosmetic launches from APAC in 2023-2024; India and China each contributed over 10 major patent filings in wound healing and skin repair.

The Asia Sericin market is USD 97.77 million in 2025 with 28% share, projected to reach USD 169.15 million by 2034 at CAGR of 6.29%, dominated by silk production hubs.

Asia - Major Dominant Countries in the Sericin Market

• China at USD 55.51 million in 2025 with 56.8% share, reaching USD 95.33 million by 2034 at CAGR of 6.47%, supported by textiles and cosmetics.
• India valued at USD 25.29 million in 2025 with 25.9% share, projected to USD 44.83 million by 2034 at CAGR of 6.50%, linked to sericulture.
• Japan estimated at USD 18.74 million in 2025 with 19.1% share, growing to USD 33.14 million by 2034 at CAGR of 6.32%, supported by cosmetics.
• South Korea at USD 13.27 million in 2025 with 13.6% share, projected to USD 23.58 million by 2034 at CAGR of 6.42%, led by personal care.
• Indonesia valued at USD 7.95 million in 2025 with 8.1% share, expected to reach USD 14.27 million by 2034 at CAGR of 6.38%, supported by food applications.

Middle East & Africa

Middle East & Africa (MEA) holds under 5-8% of global sericin market share in 2024, reflecting smaller demand but rising interest. Application use is dominated by cosmetics & personal care (~60-65%), especially in premium skincare in GCC countries; pharmaceuticals and textiles make up roughly 15-20% combined in MEA; food & beverages around 5%. Form usage: solid sericin comprises about 60-65% in MEA; liquid ~35-40%. Raw material potential exists due to silk byproduct availability; several silk farming areas in Africa provide pupae or cocoon waste used in sericin research—around 20-25% of extraction pilot projects in MEA leverage waste streams.

The Middle East and Africa Sericin market is USD 26.67 million in 2025 with 7.6% share, projected to reach USD 49.02 million by 2034 at CAGR of 6.84%, supported by growing cosmetic imports.

Middle East and Africa - Major Dominant Countries in the Sericin Market

• Saudi Arabia at USD 7.73 million in 2025 with 29% share, projected to USD 14.61 million by 2034 at CAGR of 6.87%, driven by premium skincare.
• South Africa valued at USD 6.40 million in 2025 with 24% share, reaching USD 11.79 million by 2034 at CAGR of 6.70%, linked to textile adoption.
• United Arab Emirates estimated at USD 5.60 million in 2025 with 21% share, growing to USD 10.48 million by 2034 at CAGR of 6.95%, supported by cosmetics imports.
• Nigeria at USD 3.86 million in 2025 with 14.5% share, projected to USD 7.00 million by 2034 at CAGR of 6.65%, supported by healthcare.
• Egypt valued at USD 3.08 million in 2025 with 11.5% share, reaching USD 5.14 million by 2034 at CAGR of 6.10%, with food additive demand.

List of Top Sericin Companies

• Specialty Natural Products Public Company Limited
• Seidecosa
• Hangzhou Lin Ran
• LANXESS
• Dadilan
• Huzhou Xintiansi Bio-tech
• Hubei Hongxin Ruiyu
• Huzhou Aotesi Bio-chemical
• Hubei Wande
• Wuhan Yuancheng
• DSM

Top Two Companies With Highest Share

• Specialty Natural Products Public Company Limited: Holds approximately 18–20% of the global sericin market, driven by large-scale solid sericin production. Strong presence in cosmetics and pharmaceutical-grade supply across North America, Europe, and Asia-Pacific.
• Seidecosa: Accounts for about 14–16% of global market share, with strength in high-purity sericin. Well positioned in European cosmetics, medical applications, and functional textiles through advanced extraction technologies.

Investment Analysis and Opportunities

From investment angle, Sericin Market Insights indicate growing opportunities in sustainable cosmetics and pharmaceutical sectors. Cosmetic personal care alone comprises ~60-65% of application demand; therefore, investors entering cosmetic grade sericin production (solid and liquid forms) may capture high margins. Pharmaceutical applications, though currently about 10-15%, show strong potential—wound healing, tissue engineering, drug delivery studies number dozens (30-40 in recent years), which opens opportunities for companies able to supply medical-grade, high-purity sericin. Shared extraction sources such as silk cocoon, silkworm pupae, degumming wastewater are being optimized; waste stream uses appear in ~30-35% of Asia-Pacific and MEA pilot projects, representing lower cost input.

There is investment scope in R&D for extraction/purification methods: enzymatic extraction and green chemistry are appearing in about 45-50% of current research, which suggests a competitive edge for firms that can refine efficient processes. Liquid sericin product lines, despite higher packaging/stability costs (~10-15% more), are being adopted in skincare innovations in Asia and North America (approx 40-45% of new launches). For textiles, functional finishing with sericin is increasing: about 15-20% of textile producers in APAC have adopted sericin finishing in last two years.

New Product Development

In new product development within the Sericin Market, multiple innovations are emerging. Liquid sericin in nano-formulations is increasingly used in skin repair serums: recent launch pipelines show ~35-40% of new cosmetic releases in 2023-2024 using nanoscale or encapsulated sericin for enhanced bioavailability. Hydrolyzed sericin (water-soluble) forms part of ~10-12% of pharmaceutical and food / nutraceutical product developments, offering better absorption. Solid powdered sericin continues to dominate form usage (~60-65%), but innovations in spray-drying and freeze-drying allow purities above 90% protein content, lower moisture (<5%) and controlled molecular weight distributions (20-400 kDa) for application in high-end cosmetics.

New wound-healing dressings include sericin blends with collagen or hyaluronic acid; about 5-8 novel clinical/preclinical product prototypes in 2023-2024 used sericin in composite scaffolds. Skincare and hair care product launches with multifunctional sericin actives (moisturizing + anti-oxidant + UV protection) are roughly 40% of new sericin-based cosmetic products in North America and Europe. Also, product development includes vegan and cruelty-free certified sericin extracts—over 50% of new launches in Western markets in 2024 included some form of ethical certification.

Five Recent Developments

• In 2024, a major manufacturer scaled up enzymatic extraction in Asia, increasing solid sericin yield by ~25% per kg of silk cocoon in pilot operations.
• In 2023-2024, a skincare brand in Europe introduced a sericin + UV-protective peptide serum, marking one of ~40 new cosmetic launches using sericin in multifunctional formulations that year.
• Solid sericin certification initiatives: over 50% of cosmetic product lines in North America in 2024 obtained eco-certification and started specifying molecular weight (>20 kDa) in product labeling.
• Textile finishing companies in India and China (~20-25% of silk fabric producers) implemented sericin finishing in functional textiles improving softness and moisture wick performance by approx 15-20% over untreated fabrics.
• Biomedical research projects numbered ~30-40 in 2023-2024 exploring sericin for wound dressings, especially in Asia-Pacific, Europe, and North America; some product candidates already entering advanced preclinical stages.

Report Coverage of Sericin Market

The Sericin Market Report provides thorough coverage of product forms, application segments, regional distribution, company profiles, R&D trends, and technical, regulatory and market-insight data. Form segmentation includes solid sericin (powdered, freeze-dried, spray-dried) and liquid/hydrolyzed sericin; the report shows solid form commanding ~60-65% share of usage and liquid form ~35-40%, with variation by region. Application segmentation includes cosmetics & personal care (~60-65% demand), pharmaceuticals (~10-15%), textiles (~8-12%), food & beverages (~5-8%), others. The report offers molecular weight categories (20-400 kDa), purity levels, and quality grade (cosmetic, medical, industrial) breakdown. Regional coverage spans North America (USA, Canada), Europe (Germany, UK, France, Italy, Spain), Asia-Pacific (China, India, Japan, South Korea, Southeast Asia), and Middle East & Africa; share in 2024 for North America ~40-45%, Europe ~30-35%, Asia-Pacific ~22-25%, rest under 10%. Company profiling covers at least 10 key players including Specialty Natural Products, Seidecosa, LANXESS, DSM, Dadilan, Huzhou Xintiansi Bio-tech etc., with two top companies (Specialty Natural Products and Seidecosa) bearing highest market share. Technology trends covered include extraction methods (enzymatic, green chemistry), nano-delivery systems, vegan/cruelty-free certifications, multifunctional formulations. Product launches and recent developments, quality control / regulatory issues, consumer awareness data (~30-60% depending on region) are also included.

Sericin Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 370.9 Million in 2026
Market Size Value By	USD 640.76 Million by 2035
Growth Rate	CAGR of 6.22% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Solid Liquid By Application : Pharmaceuticals Cosmetics and Personal Care Textiles Food
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample